Amesite Inc. introduced its NurseMagic™ EMR, an AI‑native electronic medical record system that extends the company’s platform from a point‑of‑care assistant to a core post‑acute care infrastructure. The modular design allows the new EMR to integrate with existing legacy systems or replace them entirely, positioning Amesite to capture a share of the U.S. post‑acute care market, which is valued at more than $470 billion and projected to exceed $850 billion in the coming years.
Revenue growth has accelerated in tandem with the rollout of higher‑value product tiers. After the July 2025 launch of the Enterprise tier, Amesite reported an 82% increase in revenue for the fourth quarter. The first quarter of fiscal 2026 saw a 69% quarter‑over‑quarter rise, and the May 2025 Teams+ launch drove a 2.4‑fold jump in quarterly revenue. These gains reflect strong demand for the company’s AI‑enabled solutions across home health, hospice, skilled nursing, senior living, and home care providers.
Despite top‑line momentum, Amesite remains unprofitable. The company’s fourth‑quarter 2025 earnings per share were –$0.14, and its trailing twelve‑month EPS is –$0.88. The negative profitability underscores the heavy investment in product development and market expansion that the company is pursuing to achieve scale.
The announcement triggered a 5% pre‑market lift in Amesite’s shares, indicating investor enthusiasm for the new product and the broader post‑acute care opportunity. Analysts noted that the EMR launch is a strategic pivot that could unlock higher‑margin revenue streams, though they also cautioned that the company’s current loss profile and competitive landscape could temper long‑term upside.
Dr. Ann Marie Sastry, CEO and founder, said the launch “demonstrates our disciplined approach to building AI‑native solutions that meet the evolving needs of post‑acute care providers.” Madison Bush, Director of Corporate Operations, highlighted a 1,400% increase in website visits since January 2025 as evidence of growing market interest. Brandon Owens, VP of Sales, emphasized the EMR’s flexibility, noting that it can operate alongside legacy systems or replace them entirely, providing immediate impact without disruption.
The competitive field includes established EMR vendors such as NextGen Healthcare, Raintree Systems, and Carepatron, as well as newer entrants like Carepatron and Tebra. Amesite’s focus on AI integration and modularity differentiates it from traditional solutions, offering a more scalable and adaptable platform. However, the company must navigate pricing pressure and the need for continued investment to maintain its growth trajectory.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.